Article21 Jul 2025Patient morbidity and mortality in BPMany factors, including older age and multimorbidity, are associated with mortality in bullous pemphigoid. Read this article to find out moreLearn more
Article16 Jul 2025Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity Learn more